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Aim. To investigate the epidemiological characteristics of primary acquired nasolacrimal duct 
obstruction (PANDO). 
Method. The study was a retrospective view of medical records of inpatients and outpatients who 
developed PANDO during a 10-year study period from 1994-2003 in Split-Dalmatian County managed at 
the Eye Clinic of Split University Hospital. The total number of patients was 91.  
Result. The annual incidence of PANDO was 1.96 per 100,000 inhabitants. The mean age ± SD of 
patients was 64.3 ± 16.0 years. There were 67 (73.6%) females and 24 (28.4%) males. The female to male 
ratio was 2.8, the difference was statistically significant (p = 0.000007). The differences in occurence were 
not statistically significant (p = 0.46) and a bilateral involvement was observed in 6 (6.6%) cases. An acute 
form of PANDO occured in 50 (54.9%) of cases, and a chronic form in 41 (45.1%) of cases. Although 
prevalence of an acute form of PANDO was a little greater in warmer seasons (spring and summer) than in 
colder seasons (autumn and winter), the seasonal variations in the occurrence of PANDO were statistically 
not significant (p = 0.26). 
Conclusion. The findings of this study are important because they make possible a better disease 
evaluation and better ophthalmological service planning in the treatment of PANDO. 




Cilj. Istražiti epidemiološke značajke primarne stečene opstrukcije nazolakrimalnog kanala (PSONK). 
Metoda. Ova retrospektivna studija daje pregled hospitaliziranih i ambulantnih bolesnika s PSONK-om 
tijekom razdoblja od 10 godina, tj. od 1994. do 2003. godine u Splitsko-dalmatinskoj županiji, liječenih na 
Klinici za očne bolesti Kliničke bolnice Split. Ukupan broj bolesnika bio je 91. 
Rezultat. Godišnja incidencija PSONK-a bila je 1,96 na 100000 stanovnika. Prosječna dob ± SD 
bolesnika bila je 64,3 ± 16,0 godina. Bilo je 67 (73,6%) žena i 24 (28,4%) muškaraca. Odnos žena prema 
muškarcima bio je 2,8, što je statistički značajna razlika (p = 0,000007). Razlike u pojavi bolesti između 
desne i lijeve strane nisu statistički značajne (p = 0,64), a bilateralna pojava je primijećena u 6 (6,6%) 
slučajeva. Akutni oblik PSONK-a javio se u 50 (54,9%) slučajeva, a kronični oblik u 41 (45,1%) slučaju. 
Iako je prevalencija akutnog oblika PSONK-a nešto veća u toplijim godišnjim dobima (proljeće i ljeto), 
nego u hladnijim (jesen i zima), sezonske varijacije u pojavi PSONK-a nisu statistički značajne (p = 0,26). 
Zaključak. Rezultati ove studije su važni jer omogućavaju bolju evaluaciju bolesti i bolje planiranje 
oftalmološke službe u liječenju PSONK-a.. 
Ključne riječi: primarna stečena opstrukcija nazolakrimalnog kanala, epidemiologija 
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Inflammation of the lacrimal sac (dacryo-
cystitis) results from stasis of tears in the lacrimal 
drainage system and secondary infection mostly by 
bacteria. 
It may be present in infancy (congenital naso-
lacrimal duct obstruction), offering 2% to 6% of live 
births or may be an acquired condition1-4. The cause 
of congenital dacryocystitis usually is the non-
obliterated valve of Hasner. More than 90% infants 
are reported to outgrow the problem by the first 
year of life.5,6 
The cause of acquired lacrimal drainage 
obstruction may be primary or secondary. The 
primary acquired nasolacrimal duct obstruction 
(PANDO), the theme of this report,  results from 
inflammation of unknown cause that eventually 
leads to occlusive fibrosis of the nasolacrimal duct 
or is a result of involutional stenosis of the 
nasolacrimal duct in the elderly.5,6 The incidence of 
significant pathology of the lacrimal sac in 
clinically suspected PANDO is low, only 2-3%.7,8 
Bernandini et al. recommend that lacrimal sac biopsy 
in patients undergoing dacryocystorhinostomy 
should be performed only in those with a positive 
history for systemic disease or an abnormal 
appearing sac during surgery.8 
Secondary acquired lacrimal drainage obstruction 
(SALDO) is mostly caused by chronic sinus 
disease, naso-orbital trauma, rarely as a result of 
neoplastic involvement or secondary to incurable 
pediatric dacryocystitis. 
Acquired dacryocystitis may be acute or 
chronic. Acute dacryocystitis is presented with 
painful enlargement of the lacrimal sac and redness 
in the medial canthal angle. If not treated, 
spontaneous rupture and drainage through the skin 
is common. Chronic dacryocutaneous fistula may 
result. Acute dacryocystitis is mostly superimposed 
on the chronic condition. 
Chronic dacryocystitis is characterized by 
recurrent episodes of epiphora or mucopurulent 
discharge, often associated with a nontender 
fullness below the medial canthal tendon. 
According to available literature there was no 
precise study about incidence and other 
epidemiological characteristics of PANDO. There 
were also none from Croatia. 
The aim of this paper is the epidemiological 
analysis of PANDO according to sex, age, 
laterality, incidence, frequency of acute and chronic 
forms of the disease and seasonal variations of 
acute form of PANDO. 
 
Patients and Methods 
 
There is a rare opportunity to study PANDO 
epidemiologic characteristics in a defined population 
like in Split-Dalmatia County because practically all 
PANDO cases are managed at the Eye Clinic of Split 
University Hospital. Only county residence patients 
were included in the study (Picture 1). The study was 
designed as a retrospective review of the medical 
records of inpatients and outpatients who developed 
PANDO during a 10-year study period from 1994 to 
2003. The total number of patients in this report is 91. 
Six patients (6.6%) had PANDO on both sides during 
the same time period. In this study we excluded 18 
patients with SALDO (3 caused by incurable 
dacryocystitis in infants, 4 as a consequence of facial 




Picture 1. Geographical position of Split-Dalmatia 
County, where the examination was performed 
Slika 1. Zemljopisni položaj Splitsko-dalmatinske 
županije – područja na kojem je rađeno istraživanje 
 
Data on the Split-Dalmatia County population 
was derived from the 2001 Croatia census9 (Table 1). 
We analysed seasonal incidence of acute form of 
PANDO. The following data were collected for this 
report: permanent place of residence, age and sex 
of each patient, hospital admittance data, eye-side 
(right or left) involved, bilaterality and seasonal 
variations of acute form of PANDO. 
The diagnosis of PANDO is established by  
medical history, characteristic clinical picture, 
fluorescein dye test, difficult or impossible irrigation 
of lacrimal drainage system, contrast dacryocysto-
graphy, radiography for orbital and paranasal sinuses 
evaluation and otorhinolaryngologic examination. 
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Table 1. Age related annual incidences of primary acquired nasolacrimal duct obstruction in Split-Dalmatia 
County, 1994-2003 
Tablica 1. Godišnje pojave primarne stečene opstrukcije nazolakrimalnog kanala u odnosu na dob u Splitsko-
dalmatinskoj županiji od 1994. do 2003. godine 
 
Age (yrs.) / Godine      Inhabitants *(n) / Broj stanovnika                  Incidence rate ** / Omjer pojava 
0-9                         56                                        0.0 
10-19                        63                                        0.0 
20-29                       66                                        0.6 
30-39                      64                                        0.6 
40-49                     69                                        1.2 
50-59                      53                                        1.5 
60-69                     49                                        4.7 
70-79                      32                                        9.4 
80-89                    9                                      10.0 
> 90                     2                                      25.0 
Total / Sveukupno       463                                     1.96 




Results are presented as mean ± standard 
deviation (SD). Statistical analysis was performed 
by use of chi-square test. P value < 0.05 was 




During the 10-year period (1994-2003), patients 
with PANDO were recorded, yielding an annual 
incidence of 1.96 (range 0.0-25.0) per 100,000 
inhabitants in Split-Dalmatia County with a 
population of 463 thousand. The mean frequency 
of PANDO was 9.1 per year. The highest incidence 
found for PANDO in our survey was in the over 
90-year age group (25.0 per 100,000). 
The mean age ± SD of patients was 64.3 ± 16.0 
years, 61.3 ± 16.2 years for men and 65.4 ± 15.9 
years for women. The gender differences in age were 
not statistically significant (p < 0.001). The youngest 
patient was 22, and the oldest 94 years of age. 74% 
patients with PANDO were more than 60 years old. 
There were 67 (73.6%) females and 24 (28.4%) 
males. The female to male ratio was 2.8, the difference 
was statistically significant (p = 0.000007). 
PANDO occurred slightly more often on the left 
side than the right, yielding a rate of 1.2. The left 
side was affected in 49 cases (53.8%) and the right 
side in 42 cases (46.2%). The site differences were 
not statistically significant (p = 0.46). Bilateral 
involvement was observed in 6 (6.6%) cases. In 
this examination an acute form of PANDO occured 
in 50 (54.9%) cases and a chronic form in 41 
(45.1%) of cases (Table 2). 
The 10-year cumulative number of acute form 
of PANDO recorded per season was 12 in winter, 
14 in spring, 15 in summer and 9 in autumn. 
Although the prevalence of acute PANDO was a 
little greater in warmer seasons (spring and 
summer) than in colder seasons (autumn and 
winter), the seasonal variations in the occurrence of 




The annual incidence of PANDO was 1.96 per 
100,000 inhabitants. Assuming that an incidence 
similar to that found in the present study is 
representative of the population of Croatia, there 
should be approximately 100 cases of PANDO in 
the country per year. Generally the frequency of 
PANDO in population is 1: 50,000 people. It is 
probably a little more higher because patients with 
weaker degrees of illness are not treated. 
Advanced in years of life, the incidence of 
PANDO increases because of involutional processes 
i.e. stenosis of the nasolacrimal duct. 
Negroid races have a lower rate of illness than 
Caucasians. It is the consequence of the form of the 
skull, facial bones and nose. Namely, the members 
of Negroid races have wider, shorter and less 
curved lacrimal paths.10 
PANDO was almost three times as common in 
females than in males (2.8 : 1) similar as in the works 
of Čupak (75% : 25%) and Massaro and Tabbara.11,12 
In the work of Lee-Wing and Ashenhurst in Canada 
71% of patients were females and 29% of patients 
were males.13 Badhu et al. found 67.6% females of 
662 patients with chronic dacryocystitis in Nepal.14 
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Table 2. Epidemiologic characteristics of 91 patients with primary acquired nasolacrimal duct obstruction 
included in this study 
Tablica 2. Epidemiološke značajke 91 bolesnika s primarnom stečenom opstrukcijom nazolakrimalnog kanala 
uključenih u ovu studiju 
 
Characteristics                                                     Value 
Osobine        Vrijednost 
 
Incidence*  
Pojava                                                             1.96 (range 0.0 - 25.0) 
Age, years                       Mean ± SD                 64.3 ± 16.0 
Godine     Prosjek 
                                Men                         61.3 ± 16.2 
   Muškarci 
                                        Women                     65.4 ± 15.9 
   Žene 
Sex                                   Men                          24 (26.4%) 
Spol     Muškarci 
                                        Women                    67 (73.6%) 
   Žene 
Side involved                  Right                        42 (46.2%) 
Obuhvaćena strana Desna 
                                         Left                          49 (53.8%) 
   Lijeva  
Bilaterality                                                         6 (6.6%) 
Obostranost 
Form of PANDO             Acute                       50 (54.9%) 
Oblik PSONK-a   Akutni 
                                         Chronic                    41 (45.1%) 
   Kronični 
* Cases per 100,000 population per year / Godišnjih slučajeva na 100.000 stanovnika  
 
The natural difference in length and width of the 
lacrimonasal duct bone part has an essential 
importance on the high rate of illness in women.15-17 
PANDO is usually unilateral in nature, and 
bilaterality is rare (6.6%). The study of Zapala and 
associates in Poland revealed bilaterality in 6.0% of 
patients with obstruction of the naso-lacrimal 
duct.18 Both sides are equally involved, probably 
because no significant difference in bony diameter 
was found between the right and left side at any 
level of bony NLD.16 In our study, the main age of 
patients was 64.3, similar to the paper of  Lee-Wing 
and Ashenhurst, i.e. 60.7 years old.13 Although 
PANDO in Split-Dalmatia County residents was 
found to occur more often on the left than on the 
right side (53.8% and 46.2%, respectively), the 
difference was not statistically significant in 
contrast to Friedmann et al. who found that the 
right side is to be involved in insignificantly more 
cases than the left one.19 The inflammation of the 
lacrimal sac occurs equally on the right and left 
side. 
PANDO has seemingly more often an 
appearance in acute form because of violent 
symptoms. We expected an acute form of PANDO 
appearance to be more common in the warmer 
months (spring and summer) because of a greater 
tendency to infections, but the statistical difference 
was insignificant. Badhu et al. found that chronic 
dacryocystitis is more common in the subtropical 
plains of Nepal with a monsoon climate (87%) than 
in the high hills (13%).14 
PANDO usually occurs in the elderly especially 
in postmenopausal women. The 60 years and older 
age group accounted for 74% of all cases. 
Epidemiological characteristics of PANDO like 
age, gender, bilaterality in our study are similar             
to those of few previous reports among Cauca-
sians.13,14,18 
The findings of this study are important because 
they make a better disease evaluation possible and 
better planning of ophthalmological service in the 
treatment of PANDO. 
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